Skip to Main content Skip to Navigation
Journal articles

Long-term safety of interferon beta-1b (IFNB-1b) treatment in early multiple sclerosis ( MS): The 11-year follow-up of BENEFIT (BENEFIT-11)

Abstract : Meeting Abstract: P028 - ACTRIMS Forum, New Orleans, LA, feb 2016
Document type :
Journal articles
Complete list of metadatas

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01300794
Contributor : Laurent Jonchère <>
Submitted on : Monday, April 11, 2016 - 2:14:42 PM
Last modification on : Friday, December 6, 2019 - 4:00:04 PM

Identifiers

  • HAL Id : hal-01300794, version 1

Citation

Mark S. Freedman, Ludwig Kappos, Gilles Edan, Xavier Montalban, Hans-Peter Hartung, et al.. Long-term safety of interferon beta-1b (IFNB-1b) treatment in early multiple sclerosis ( MS): The 11-year follow-up of BENEFIT (BENEFIT-11). Multiple Sclerosis Journal, SAGE Publications, 2016, 22, pp.19--20. ⟨hal-01300794⟩

Share

Metrics

Record views

127